PTC Therapeutics, Inc.

PTCTNASDAQUSD
69.42 USD
1.65 (2.43%)🟢LIVE (AS OF 03:12 PM EDT)
🟢Market: OPEN
Open?$67.77
High?$70.24
Low?$67.08
Prev. Close?$67.77
Volume?312.2K
Avg. Volume?1.2M
VWAP?$69.52
Rel. Volume?0.26x
Bid / Ask
Bid?$69.56 × 100
Ask?$79.29 × 100
Spread?$9.73
Midpoint?$74.43
Valuation & Ratios
Market Cap?5.6B
Shares Out?82.8M
Float?75.6M
Float %?94.2%
P/E Ratio?8.22
P/B Ratio?-27.32
EPS?$8.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.35Strong
Quick Ratio?2.27Strong
Cash Ratio?1.02Strong
Debt/Equity?-1.43Low
ValuationATTRACTIVELY VALUED
Score
94/100
P/E?
8.2CHEAP
P/B?
-27.32CHEAP
P/S?
3.24FAIR
P/FCF?
8.0CHEAP
EV/EBITDA?
5.5CHEAP
EV/Sales?
2.84CHEAP
Returns & Efficiency
ROE?
-332.5%WEAK
ROA?
23.5%STRONG
Cash Flow & Enterprise
FCF?$702.3M
Enterprise Value?$4.9B
Related Companies
Loading...
News
Profile
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Employees
991
Market Cap
5.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2013-06-20
Address
500 WARREN CORPORATE CENTER DRIVE
WARREN, NJ 07059
Phone: (908) 222-7000